These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 7528477

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Possible contribution of PDGF-BB-induced autophagy in dermatofibrosarcoma protuberans: Autophagy marker Atg5 could be a differential marker between dermatofibrosarcoma protuberans and dermatofibroma.
    Motegi SI, Fujiwara C, Sekiguchi A, Yamazaki S, Yokoyama Y, Yasuda M, Ishikawa O.
    J Dermatol Sci; 2019 Feb; 93(2):139-141. PubMed ID: 30704939
    [No Abstract] [Full Text] [Related]

  • 23. Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors. Dermatofibrosarcoma protuberans and giant cell fibroblastoma.
    Sandberg AA, Bridge JA.
    Cancer Genet Cytogenet; 2003 Jan 01; 140(1):1-12. PubMed ID: 12550751
    [No Abstract] [Full Text] [Related]

  • 24. Expression of the human progenitor cell antigen CD34 (HPCA-1) distinguishes dermatofibrosarcoma protuberans from fibrous histiocytoma in formalin-fixed, paraffin-embedded tissue.
    Kutzner H.
    J Am Acad Dermatol; 1993 Apr 01; 28(4):613-7. PubMed ID: 7681857
    [Abstract] [Full Text] [Related]

  • 25. The Immunological Roles of Periostin/Tumor-Associated Macrophage Axis in Development of Dermatofibrosarcoma Protuberans.
    Fujimura T, Kakizaki A, Sato Y, Tanita K, Furudate S, Aiba S.
    Anticancer Res; 2017 Jun 01; 37(6):2867-2873. PubMed ID: 28551623
    [Abstract] [Full Text] [Related]

  • 26. D2-40, a novel immunohistochemical marker in differentiating dermatofibroma from dermatofibrosarcoma protuberans.
    Bandarchi B, Ma L, Marginean C, Hafezi S, Zubovits J, Rasty G.
    Mod Pathol; 2010 Mar 01; 23(3):434-8. PubMed ID: 20062007
    [Abstract] [Full Text] [Related]

  • 27. Differential expression of connective tissue growth factor gene in cutaneous fibrohistiocytic and vascular tumors.
    Igarashi A, Hayashi N, Nashiro K, Takehara K.
    J Cutan Pathol; 1998 Mar 01; 25(3):143-8. PubMed ID: 9550312
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Low proliferative activity in common dermatofibroma does not necessarily guarantee a low proliferation in all dermatofibroma variants.
    Fernandez-Flores A.
    Arch Pathol Lab Med; 2008 Feb 01; 132(2):160; author reply 160-1. PubMed ID: 18251566
    [No Abstract] [Full Text] [Related]

  • 31. A novel COL1A1 exon 14/PDGFB fusion gene in dermatofibrosarcoma protuberans.
    Muchemwa FC, Jinnin M, Wakasugi S, Sakamoto M, Inoue Y, Ishihara T, Ihn H.
    Eur J Dermatol; 2010 Feb 01; 20(3):390-1. PubMed ID: 20133221
    [No Abstract] [Full Text] [Related]

  • 32. Expression of embryonic stem cell markers SOX2 and nestin in dermatofibrosarcoma protuberans and dermatofibroma.
    Sellheyer K, Nelson P, Patel RM.
    J Cutan Pathol; 2011 May 01; 38(5):415-9. PubMed ID: 21251041
    [Abstract] [Full Text] [Related]

  • 33. LN-2 (CD74). A marker to distinguish atypical fibroxanthoma from malignant fibrous histiocytoma.
    Lazova R, Moynes R, May D, Scott G.
    Cancer; 1997 Jun 01; 79(11):2115-24. PubMed ID: 9179057
    [Abstract] [Full Text] [Related]

  • 34. S100A6 expression in fibrohistiocytic lesions.
    Fullen DR, Reed JA, Finnerty B, McNutt NS.
    J Cutan Pathol; 2001 May 01; 28(5):229-34. PubMed ID: 11401666
    [Abstract] [Full Text] [Related]

  • 35. Sclerotic Fibroma-Like Dermatofibrosarcoma Protuberans With Pleomorphic Sarcomatous Transformation: A Diagnostic Challenge.
    Saggini A, Cerroni L, Balzarini P, di Prete M, Lora V, Cota C.
    Am J Dermatopathol; 2021 Apr 01; 43(4):315-317. PubMed ID: 32732686
    [No Abstract] [Full Text] [Related]

  • 36. [Fibrosarcomatous dermatofibrosarcoma protuberans: a clinicopathological analysis of 12 cases].
    Zhang J, Wu N, Xia C, Wei X, Shi QL, Zhou XJ, Ma J.
    Zhonghua Bing Li Xue Za Zhi; 2013 Nov 01; 42(11):753-7. PubMed ID: 24447553
    [Abstract] [Full Text] [Related]

  • 37. Stromelysin-3 expression in the differential diagnosis of dermatofibroma and dermatofibrosarcoma protuberans: comparison with factor XIIIa and CD34.
    Kim HJ, Lee JY, Kim SH, Seo YJ, Lee JH, Park JK, Kim MH, Cinn YW, Cho KH, Yoon TY.
    Br J Dermatol; 2007 Aug 01; 157(2):319-24. PubMed ID: 17596171
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. [Atrophic dermatofibrosarcoma protuberans: report of a case].
    Han XY, Wei HQ, Pan Q, Liu J.
    Zhonghua Bing Li Xue Za Zhi; 2013 Jan 01; 42(1):52-3. PubMed ID: 23611277
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.